SMC says ‘no’ to Novartis’ Kymriah for adults with lymphoma
Adults with lymphoma will not be able to access Novartis’ CAR-T therapy Kymriah on the NHS in Scotland after cost-regulators rejected funding for the treatment in this setting.
Read More
Author: Selina McKee
Takeda’s Entyvio bests AbbVie’s Humira in ulcerative colitis trial
Takeda’s Entyvio has beaten AbbVie’s Humira on achieving clinical remission in patients with ulcerative colitis, in the first trial to directly compare the efficacy and safety of two commonly used biologics for the disease.
Read More
Allergan files anti-CGRP migraine drug in the US
US regulators have accepted for review Allergan’s application to market ubrogepant for the acute treatment of migraine.
Read More
Gov’t offers £56m for research into public health challenges
Health Minister Nicola Blackwood has announced up to £56 million funding for research into the biggest challenges facing public health – climate change, air pollution, antimicrobial resistance and global pandemics.
Read More
Public unaware of how to verify legitimacy of online pharmacies, survey finds
Millions of people in the UK could be putting their health at risk because they do not know how to check the safety of medicines they bought online, suggest findings of a new survey.
Read More- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
